https://www.barrons.com/articles/eli-lilly-to-buy-point-biopharma-457b85b7
0
0
10/3/23 at 1:41pm
Organization
Barron's
29 words
0
Comments
Drug maker Eli Lilly agreed to acquire radiopharmaceutical company Point Biopharma Global for $12.50 a share.
You are the first to view
Create an account
or login to join the discussion